Claudia Chan

Mesothelioma Research & Treatment in Europe/United Kingdom
Prof Paul Baas has been interested in mesothelioma for many years. He has focused on translational research. He participated in many clinical studies and was the first author of the practice changing study of IO combination in mesothelioma. He has published over 350 paper and is currently focusing on the supportive care of patients with mesothelioma in The Netherlands. He is currently the chairperson for the Rare Tumors group of the IASLC and has functioned in the iMig for many years as board member.